| Oct 4 |
CPRX or STVN: Which Is the Better Value Stock Right Now?
|
| Oct 1 |
Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?
|
| Oct 1 |
Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
|
| Sep 24 |
Catalyst Pharmaceuticals: High Valuation Amid Weak Long-Term Prospects (Rating Downgrade)
|
| Sep 24 |
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan
|
| Sep 13 |
High Growth Tech Stocks In The United States You Should Know
|
| Sep 10 |
Despite lower earnings than three years ago, Catalyst Pharmaceuticals (NASDAQ:CPRX) investors are up 293% since then
|
| Sep 6 |
Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
|
| Sep 2 |
Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today
|
| Aug 22 |
Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating & Scientific Officer ...
|
